Bioorganic & Medicinal Chemistry Letters 2008-01-01

Novel and efficient synthesis and antifungal evaluation of 2,3-functionalized cholestane and androstane derivatives

Branko S. Jursic, Sunil Kumar Upadhyay, Clinton C. Creech, Donna M. Neumann, Branko S. Jursic, Sunil Kumar Upadhyay, Clinton C. Creech, Donna M. Neumann

文献索引:Bioorg. Med. Chem. Lett. 20 , 7372-5, (2010)

全文:HTML全文

摘要

Synthetic modifications of cholesterol and other traditional steroid molecules have become a promising area for the exploration and development of novel antifungal agents, especially with respect to the development of fatty-acid esters of steroids. In addition, 2,3-functionalized steroids are also compounds with potentially interesting biological properties and proper functionalization of 2,3-steroids can lead to the development of efficient syntheses of building blocks for novel fatty-acid esters of steroids. In this Letter, we outline a novel and efficient approach to the synthesis of 2,3-functionalized cholestane and androstane derivatives and present their promising preliminary antifungal activities against a number of fungal species.Copyright © 2010 Elsevier Ltd. All rights reserved.


相关化合物

  • 5α-Androstan-3β-ol
  • 5-ALPHA-雄烷
  • 二氢胆固醇

相关文献:

Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.

2005-09-08

[J. Med. Chem. 48 , 5666-74, (2005)]

The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors.

2006-05-01

[J. Pharmacol. Exp. Ther. 317(2) , 694-703, (2006)]

Synthesis of novel D-ring fused 7'-aryl-androstano[17,16-d][1,2,4] triazolo[1,5-a]pyrimidines.

2012-04-01

[Steroids 77(5) , 367-74, (2012)]

Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP.

2003-06-01

[Carcinogenesis 24(6) , 1059-65, (2003)]

Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation.

2009-11-01

[Br. J. Pharmacol. 158(5) , 1322-9, (2009)]

更多文献...